Related Experiment Videos
Constitutional WT1 mutations in Wilms' tumor patients
L Diller1, M Ghahremani, J Morgan
1Dana-Farber Cancer Institute, Boston, MA 02115, USA. lisa_diller@dfci.harvard.edu
Summary
Constitutional WT1 gene mutations are linked to Wilms' tumors (WT), particularly in patients with genitourinary anomalies like cryptorchidism. This study identified a higher frequency of WT1 mutations in these patients, suggesting a predisposition.
Area of Science:
- Genetics
- Pediatric Oncology
- Molecular Biology
Background:
- Constitutional WT1 gene mutations are rarely reported in Wilms' tumors (WT).
- Previous studies were limited to case reports and small case series.
- Understanding the frequency and clinical associations of WT1 mutations is crucial for risk stratification.
Purpose of the Study:
- To determine the frequency of constitutional WT1 mutations in a larger cohort of Wilms' tumor patients.
- To identify clinical manifestations associated with an increased risk of carrying a WT1 mutation.
Main Methods:
- Collected clinical data and blood samples from 201 patients with a history of WT.
- Performed DNA analysis including Southern blot, SSCP, and direct DNA sequencing.
- Calculated odds ratios (ORs) for WT1 mutation carriage based on clinical risk factors.
Main Results:
- Eight of 201 patients (4%) carried WT1 gene mutations, mostly protein-truncating.
- No mutations were found in patients with isolated unilateral WT.
- Genitourinary anomalies significantly increased the odds of carrying a WT1 mutation (OR 19.3; P < .002).
- Seven of 28 boys with WT and cryptorchidism had WT1 mutations.
Conclusions:
- Germline WT1 mutations in Wilms' tumor patients are strongly associated with genitourinary anomalies, particularly cryptorchidism and hypospadias.
- Patients with WT and no genitourinary anomalies have a low risk of harboring a WT1 mutation.
- Truncated WT1 proteins may contribute to the development of cryptorchidism, hypospadias, and Wilms' tumors.